Publications by authors named "Gary Herman"

Claim this Profile
D
DB-OTO Gene Therapy for Inherited Deafness.
Vassili Valayannopoulos, Manohar Bance, Daniela S Carvalho, John H Greinwald, Steven A Harvey, Gary A Herman

N Engl J Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The IL-33 and IL-4Rα blocking antibodies itepekimab and dupilumab modulate both distinct and common inflammatory mediators in asthma.
Seblewongel Asrat, Wei Keat Lim, Subhashini Srivatsan, Sivan Harel, Kaitlyn Gayvert, Gary A Herman

Sci Transl Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Interchangeability of PD-L1 Immunohistochemistry Assays in First-Line Non-Small Cell Lung Cancer Management With Cemiplimab.
Javier Perez, Keith M Kerr, Brian Baker, Fang Fang, Jason Li, Gary Herman

JCO Precis Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GDF8 and activin A are the key negative regulators of muscle mass in postmenopausal females: a randomized phase I trial.
Dinko Gonzalez Trotter, Stephen Donahue, Chris Wynne, Shazia Ali, Prodromos Parasoglou, Gary A Herman

Nat Commun· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of timing of casirivimab and imdevimab administration relative to mRNA-1273 COVID-19 vaccination on vaccine-induced SARS-CoV-2 neutralising antibody responses: a prospective, open-label, phase 2, randomised controlled trial.
Flonza Isa, Ana M Gonzalez Ortiz, Jonathan Meyer, Jennifer D Hamilton, Benjamin A Olenchock, Gary A Herman

Lancet Infect Dis· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of PET/CT versus CT only in the assessment of new heterotopic ossification bone lesions in patients with fibrodysplasia ossificans progressiva.
Dinko González Trotter, Jennifer McGinniss, Kusha Mohammadi, Bret J Musser, Gary A Herman

Bone· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Pharmacokinetics of Casirivimab and Imdevimab (CAS + IMD) in Pediatric Outpatients With COVID-19.
Thomas D Norton, Mazhar Thakur, Samit Ganguly, Shazia Ali, Jesse Chao, Gary A Herman

J Pediatric Infect Dis Soc· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monoclonal antibodies against the spike protein alter the endogenous humoral response to SARS-CoV-2 vaccination and infection.
Christopher D Petro, Andrea T Hooper, Avery Peace, Kusha Mohammadi, Will Eagan, Gary A Herman

Sci Transl Med· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the safety and pharmacokinetics of casirivimab and imdevimab (CAS+IMD) in a cohort of pregnant outpatients with COVID-19: results from an adaptive, multicentre, randomised, double-blind, phase 1/2/3 study.
Thomas D Norton, Mazhar Thakur, Samit Ganguly, Shazia Ali, Jesse Chao, Gary A Herman

BMJ Open· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Agonist antibody to guanylate cyclase receptor NPR1 regulates vascular tone.
Michael E Dunn, Aaron Kithcart, Jee Hae Kim, Andre Jo-Hao Ho, Matthew C Franklin, Gary Herman

Nature· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential modulation of allergic rhinitis nasal transcriptome by dupilumab and allergy immunotherapy.
Matthew F Wipperman, Kaitlyn M Gayvert, Amanda Atanasio, Claire Q Wang, Jonathan Corren, Gary Herman

Allergy· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nasopharyngeal Viral Load Is the Major Driver of Incident Antibody Immune Response to SARS-CoV-2 Infection.
Meng Xu, Meagan P O'Brien, Andrea T Hooper, Eduardo Forleo-Neto, Flonza Isa, Gary A Herman

Open Forum Infect Dis· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical, randomized phase 1, and compassionate use evaluation of REGN4461, a leptin receptor agonist antibody for leptin deficiency.
Judith Y Altarejos, Jeffrey Pangilinan, Simona Podgrabinska, Baris Akinci, Maria Foss-Freitas, Gary A Herman

Sci Transl Med· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Garetosmab in fibrodysplasia ossificans progressiva: a randomized, double-blind, placebo-controlled phase 2 trial.
Maja Di Rocco, Eduardo Forleo-Neto, Robert J Pignolo, Richard Keen, Philippe Orcel, Gary A Herman

Nat Med· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Prospective Study of Key Correlates for Household Transmission of Severe Acute Respiratory Syndrome Coronavirus 2.
Elizabeth R Brown, Meagan P O'Brien, Brian Snow, Flonza Isa, Eduardo Forleo-Neto, Gary Herman

Open Forum Infect Dis· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Examining protective effects of SARS-CoV-2 neutralizing antibodies after vaccination or monoclonal antibody administration.
Dean Follmann, Meagan P O'Brien, Jonathan Fintzi, Michael P Fay, David Montefiori, Gary A Herman

Nat Commun· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness of Casirivimab and Imdevimab Antibody Combination in Immunocompromised Hospitalized Patients With Coronavirus Disease 2019: A Post Hoc Analysis in a Phase 1/2/3 Double-Blind Trial.
Selin Somersan-Karakaya, Eleftherios Mylonakis, Jenni Mou, Ernesto Oviedo-Orta, Meagan P O'Brien, Gary A Herman

Open Forum Infect Dis· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Casirivimab and Imdevimab for the Treatment of Hospitalized Patients With COVID-19.
Selin Somersan-Karakaya, Eleftherios Mylonakis, Vidya P Menon, Jason C Wells, Shazia Ali, Gary A Herman

J Infect Dis· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
REGN1908/1909 prevented cat allergen-induced early asthmatic responses in an environmental exposure unit.
Frederic J de Blay, Alina Gherasim, Nathalie Domis, Pretty Meier, Furat Shawki, Gary Herman

J Allergy Clin Immunol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Casirivimab and Imdevimab Treatment Reduces Viral Load and Improves Clinical Outcomes in Seropositive Hospitalized COVID-19 Patients with Nonneutralizing or Borderline Neutralizing Antibodies.
Andrea T Hooper, Selin Somersan-Karakaya, Shane E McCarthy, Eleftherios Mylonakis, Shazia Ali, Gary A Herman

mBio· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of a single dose of casirivimab and imdevimab for the prevention of COVID-19 over an 8-month period: a randomised, double-blind, placebo-controlled trial.
Gary A Herman, Meagan P O'Brien, Eduardo Forleo-Neto, Neena Sarkar, Flonza Isa

Lancet Infect Dis· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Repeat subcutaneous administration of casirivimab and imdevimab in adults is well-tolerated and prevents the occurrence of COVID-19.
Flonza Isa, Eduardo Forleo-Neto, Jonathan Meyer, Wenjun Zheng, Scott Rasmussen, Gary A Herman

Int J Infect Dis· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Sarilumab in Hospitalized Patients With Coronavirus Disease 2019: A Randomized Clinical Trial.
Sumathi Sivapalasingam, David J Lederer, Rafia Bhore, Negin Hajizadeh, Gerard Criner, Gary A Herman

Clin Infect Dis· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Virologic Efficacy of Casirivimab and Imdevimab COVID-19 Antibody Combination in Outpatients With SARS-CoV-2 Infection: A Phase 2 Dose-Ranging Randomized Clinical Trial.
Cynthia Portal-Celhay, Eduardo Forleo-Neto, Will Eagan, Bret J Musser, John D Davis, Gary A Herman

JAMA Netw Open· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Subcutaneous Casirivimab and Imdevimab Antibody Combination vs Placebo on Development of Symptomatic COVID-19 in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical Trial.
Meagan P O'Brien, Eduardo Forleo-Neto, Neena Sarkar, Flonza Isa, Peijie Hou, Gary Herman

JAMA· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis